Gastroenterology & Hepatology

Gut health, IBD/IBS, reflux, liver disease, and microbiome research.

  • 5 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Gastroenterology & Hepatology


seekingalpha.com > news > 4652284-johnson-and-johnson-long-term-tremfya-data-demonstrates-crohns-remission-through-three-years

J&J long-term Tremfya data demonstrates Crohn's remission through three years

1+ hour, 26+ min ago   (60+ words) Three-year phase 3 data show Tremfya boosts Crohn’s remission rates up to 94%. Read more here. Md Saiful Islam Khan Long-term data from two phase 3 studies showed that adults with Crohn's disease treated with Tremfya (guselkumab) saw clinical remission rates of up…...


healthtalk.unchealthcare.org > treatment-options-for-inflammatory-bowel-disease

Treatment Options for Inflammatory Bowel Disease

3+ week, 3+ day ago   (989+ words) Everyone has diarrhea every now and then, but if you notice it’s happening regularly, tell your doctor, especially if you’re also experiencing abdominal pain, bloody stool, unintended weight loss and fatigue. It could be inflammatory bowel disease (IBD), an umbrella…...


guardonline.com > news > national > isothrive-final-phase-2-results-for-mhs-1031-announced-at-acg-2026-demonstrate-statistically-significant > article_3b706e9d-eaa6-591b-99e3-7d8608ea0915.html

ISOThrive Final Phase 2 Results for MHS-1031 Announced at ACG 2026 Demonstrate Statistically Significant and Clinically Meaningful Improvement in Heartburn Frequency and Severity in NERD PPI-Partial Responders

5+ hour, 10+ min ago   (179+ words) ACG Presidential Poster Award winner for high quality, novel, unique, or interesting research Highly significant improvements in RESQ-eD Regurgitation scores were also observed, reflecting a potential new treatment result not observed with PPIs and PCABs. "Current acid-suppressive therapies do not…...


prnewswire.com > news-releases > tremfya-guselkumab-demonstrated-sustained-clinical-and-endoscopic-remission-through-3-years-in-moderately-to-severely-active-crohns-disease-302906078.html

TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease

2+ hour, 37+ min ago   (749+ words) Oct 12, 2026, 16:05 ET Clinical and endoscopic outcomes sustained through three years with TREMFYA Patients in the GALAXI 2 and 3 studies received intravenous induction followed by one of two TREMFYA maintenance dosing regimens: 100 mg administered subcutaneously every eight weeks (q8w) or 200 mg administered subcutaneously…...


earth.com > lifestyle > antibiotics-and-sugar-new-evidence-shows-why-the-two-dont-mix

Antibiotics and sugar: New evidence shows why the two don’t mix

3+ hour, 34+ min ago   (1179+ words) Patients who ate more sugar while on antibiotics lost more gut bacteria diversity, and sucrose amplified the same effect in mice. When someone is too sick to eat, families and nurses push whatever calories will go down. Nutrition shakes, smoothies,…...


newswise.com > articles > protein-puts-brakes-on-intestinal-inflammation-utsw-study-finds

Protein Puts Brakes on Intestinal Inflammation, UTSW Study Finds

7+ hour, 7+ min ago   (337+ words) Dr. Poojary led the research with first author Mahesh Kathania, Ph.D., Instructor of Internal Medicine in the Division of Digestive and Liver Diseases, and Desh Raj, Ph.D., a postdoctoral researcher in the Poojary Lab. IBD, which includes Crohn’s disease and…...


nutritionnews.abbott > pregnancy-childhood > infant-toddler > six-ways-to-boost-your-childs-immune-system

Gut Health and Your Child's Immune System

3+ day, 7+ hour ago   (1010+ words) By Rachael Buck, PhD, researcher and immune health expert at Abbott It's a simple fact: kids tend to get sick a lot when they're young. In fact, children under age 6 get an average of six to eight colds a year,…...


cysticfibrosisnewstoday.com > news > cf-treatment-linked-shifts-gut-lung-microbiome-activity

CF therapy linked to shifts in gut and lung microbiome activity

4+ day, 6+ hour ago   (468+ words) One-year study found modest composition changes but larger functional shifts Written by Margarida Maia, PhD | Oct. 8, 2026 Kaftrio, a CFTR modulator marketed as Trikafta (elexacaftor/tezacaftor/ivacaftor) in the U.S., was associated with improved lung function and nutritional status in a study....


medicalrepublic.com.au > when-adhd-treatment-puts-appetite-on-pause > 129923

When ADHD treatment puts appetite on pause

12+ hour, 28+ min ago   (1541+ words) Appetite suppression is common with stimulant treatment for ADHD, but it does not always translate into growth or nutritional problems. While generally well tolerated, reduced appetite is one of the most commonly reported adverse effects of stimulant medication for ADHD…...


bioengineer.org > dual-target-antibody-strikes-two-inflammatory-pathways-to-ease-colitis-in-mice

Dual-Target Antibody Strikes Two Inflammatory Pathways to Ease Colitis in Mice

3+ hour, 19+ min ago   (680+ words) Scientists have engineered a bispecific antibody that simultaneously blocks TL1A and IL-12/23p40, suppressing pathogenic Th1/Th17 immune responses and significantly ameliorating colitis in humanized mice....